Showing results (101-110 of 265) with videos related to
Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patientsG Bocci, R Danesi, A D Di Paolo, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 1, 1996
FK-506 delays corneal graft rejection in a model of corneal xenotransplantationU Benelli, A Lepri, M Del Tacca, et al.The Journal of Pharmacy and Pharmacology|July 1, 1992
Atrial natriuretic peptide inhibits the spontaneous contractions of rabbit isolated ileumC Blandizzi, C Agen, G Natale, et al.Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1986
The effects of alpha-2 agonists and antagonists on gastric acid secretionC Bernardini, M Del Tacca, G Soldani, et al.British Journal of Pharmacology|April 1, 2000
Histamine H(3) receptors mediate inhibition of noradrenaline release from intestinal sympathetic nervesC Blandizzi, M Tognetti, R Colucci, et al.Pharmacology|January 1, 1984
Comparative study of pA2 values of pirenzepine and atropine for guinea-pig gastric fundus and gastric smooth muscleM Del Tacca, G Soldani, C Bernardini, et al.The Journal of Clinical Endocrinology and Metabolism|June 1, 1996
Clinical and experimental evidence of inhibition of testosterone production by suraminR Danesi, R V La Rocca, M R Cooper, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC)C Bengala, I Pazzagli, F Innocenti, et al.British Journal of Cancer|April 30, 2008
Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinibG Bocci, A Falcone, A Fioravanti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancerP F Conte, E Baldini, A Gennari, et al.Pageof 27